← Eichor
Study identifier: NCT05164328 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prospective Athlete's Heart Study

Condition: Athlete Heart  ·  Sponsor: Universitaire Ziekenhuizen KU Leuven

PhaseN/A
Planned participants450
Who can joinAll sexes, 14 Years to 23 Years
Healthy volunteersYes

About this study

The Pro@Heart (Prospective Athlete's Heart) study is an international multicentre long-term prospective trial. The primary objective of the Pro@Heart study is to investigate the impact of training load (i.e. accurately evaluated in term of type, frequency, duration and intensity) and genotype on the variability of structural, functional and electrical exercise induced cardiac remodeling (EICR) in young competitive endurance athletes. The second objective is to determine how EICR, training load and genotype are associated with physical performance, health benefits and cardiac pathology (e.g. exercise-related cardiomyopathies and arrhythmias) during follow-up over several decades.

This description comes directly from the study's public registry record.

Talk to the study team

Guido Claessen, Prof. Dr.  ·  guido.claessen@uzleuven.be

Always discuss trial participation with your own doctor first.

Locations (4)

Baker Heart and Diabetes InstituteMelbourne, Victoria, AustraliaRecruiting
UZ AntwerpenEdegem, Antwerp, BelgiumRecruiting
Jessa Ziekenhuis HasseltHasselt, Limburg, BelgiumRecruiting
UZ LeuvenLeuven, Vlaams Brabants, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05164328